近日，中华中医药学会正式发布《类风湿关节炎病证结合诊疗指南（2025年）》。这一行业重磅文件的出台，标志着类风湿关节炎（RA）中医诊疗迈入更科学、规范的新阶段。其中，广药集团旗下白云山陈李济昆仙胶囊凭借确切临床疗效与高质量循证医学证据，成功获指南“强推荐”，稳居中成药治疗类风湿关节炎（RA）辨病治疗的首选产品行列。指南突破性亮点无需严格辨证，昆仙胶囊为基础治疗用药传统中医诊疗中，中成药使用常依赖...
Source Link近日，中华中医药学会正式发布《类风湿关节炎病证结合诊疗指南（2025年）》。这一行业重磅文件的出台，标志着类风湿关节炎（RA）中医诊疗迈入更科学、规范的新阶段。其中，广药集团旗下白云山陈李济昆仙胶囊凭借确切临床疗效与高质量循证医学证据，成功获指南“强推荐”，稳居中成药治疗类风湿关节炎（RA）辨病治疗的首选产品行列。指南突破性亮点无需严格辨证，昆仙胶囊为基础治疗用药传统中医诊疗中，中成药使用常依赖...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.